pegvisomant

Ligand id: 7485

Name: pegvisomant

References
1. Schreiber I, Buchfelder M, Droste M, Forssmann K, Mann K, Saller B, Strasburger CJ, German Pegvisomant Investigators. (2007)
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study.
Eur. J. Endocrinol.156 (1): 75-82. [PMID:17218728]
2. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML et al.. (2000)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
N. Engl. J. Med.342 (16): 1171-7. [PMID:10770982]